Skip to Content

Predictive Technology Group Inc PRED

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PRED is trading at a 564% premium.
Price
$0.00
Fair Value
$8.43
Uncertainty
Extreme
1-Star Price
$2.15
5-Star Price
$3.46
Economic Moat
Ymnf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRED is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.04
Bid/Ask
$0.05 / $0.07
Market Cap
$209,717.77
Volume/Avg
289,710 / 68,225

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
64

Valuation

Metric
PRED
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PRED
Quick Ratio
0.08
Current Ratio
0.29
Interest Coverage
−64.70
Quick Ratio
PRED

Profitability

Metric
PRED
Return on Assets (Normalized)
−32.13%
Return on Equity (Normalized)
−50.64%
Return on Invested Capital (Normalized)
−41.32%
Return on Assets
PRED
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRRbtwkqcmxMgcxr$586.3 Bil
VRTX
Vertex Pharmaceuticals IncFcjbgktggBndclc$115.1 Bil
REGN
Regeneron Pharmaceuticals IncWyjkpxnmBndvgt$108.2 Bil
MRNA
Moderna IncKdjbmpvjBkjm$54.0 Bil
ARGX
argenx SE ADRDmwgyzjjwYqxg$22.0 Bil
BNTX
BioNTech SE ADRZylmyskBtf$21.8 Bil
ALNY
Alnylam Pharmaceuticals IncHxzdnlbcMrfmdt$18.9 Bil
BMRN
Biomarin Pharmaceutical IncKqrtjqhdXzwjqg$14.6 Bil
INCY
Incyte CorpBdwxbhjbgLdqwrmx$12.9 Bil
RPRX
Royalty Pharma PLC Class AGdbqnjmwhLyxrgm$12.3 Bil

Sponsor Center